US PATENT SUBCLASS 604 / 501
.~.~.~ Enhanced absorption of therapeutic material internally using iontophoretic treatment


Current as of: June, 1999
Click HD for Main Headings
Click for All Classes

Internet Version by PATENTEC © 1999      Terms of Use



604 /   HD   SURGERY

19  DF  MEANS FOR INTRODUCING OR REMOVING MATERIAL FROM BODY FOR THERAPEUTIC PURPOSES (E.G., MEDICATING, IRRIGATING, ASPIRATING, ETC.) {7}
48  DF  .~ Treating material introduced into or removed from body orifice, or inserted or removed subcutaneously other than by diffusing through skin {9}
500  DF  .~.~ Method {8}
501.~.~.~ Enhanced absorption of therapeutic material internally using iontophoretic treatment


DEFINITION

Classification: 604/501

Enhanced absorption of therapeutic material internally using iontophoretic treatment:

(under subclass 500) Subject matter for a process of subjecting the patient to an in-situ electromagnetic field to facilitate the transfer of a body treating composition to endothelial cells cellular membranes, body tissue, internal organs or benign and malignant tissue growths.

(1) Note. Endothelial cells are those cells, which line the insides of blood or lymph vessels and some other closed cavities.

(2) Note. Methods disclosing the injection of contrast mediums are not treating materials as such and should be placed with the appropriate diagnostic device.

(3) Note. Electroporation therapies are appropriate subject matter for this subclass.

SEE OR SEARCH THIS CLASS, SUBCLASS:

20, for iontophoretic devices.

502, for peritoneal access devices (PADs).

892.1, for therapeutic delivery devices, which forcibly dispense body treating material by pressure created by osmosis or diffusion of fluid through the epidermis. SEE OR SEARCH CLASS

424, Drug, Bio-Affecting and Body Treating Composition,

424+, for preparations characterized by special physical form including a membrane across which osmosis or diffusion may occur in which the osmosis or diffusion bring fluid into direct contact with the medicinal composition.